Blandine Lacroix

Senior Vice President, Strategy & Rare Disease at Novo Nordisk

No bio yet

Links


Timeline

  • Senior Vice President, Strategy & Rare Disease

    February, 2023 - present

  • Corporate Vice President, Strategy & Rare Disease

    September, 2020

  • Corporate Vice President, Obesity Business Unit

    October, 2017

  • Vice President - Obesity Marketing

    March, 2013

  • Vice President - Diabetes Marketing

    January, 2011

  • Corporate Vice President & Project Vice President

    January, 2010

  • Corporate Vice President - Global Marketing

    September, 2008

  • Senior International Marketing Director

    September, 2006

  • Marketing Director - Diabetes

    December, 2003

  • Group Product Manager

    April, 2002